Post by A*STAR Infectious Diseases Labs - A*STAR IDL

𝗔𝗣𝗩𝗜𝗖 𝟮𝟬𝟮𝟲, 𝗗𝗮𝘆 𝟮: 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗴𝗹𝗼𝗯𝗮𝗹 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽. 🌏⚡ Day 2 of the 𝗔𝘀𝗶𝗮𝗣𝗮𝗰𝗶𝗳𝗶𝗰 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 & 𝗜𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 (#APVIC2026) highlighted the scale, depth, and connectivity of today’s global vaccines and immunotherapy ecosystem. We are encouraged by a 𝗿𝗲𝗰𝗼𝗿𝗱 𝗹𝗲𝘃𝗲𝗹 𝗼𝗳 𝗮𝗯𝘀𝘁𝗿𝗮𝗰𝘁 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻𝘀 this year — a clear reflection of the rapid scientific progress and growing urgency across the field. The breadth of work presented spans 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀, 𝗶𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝘆, 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, 𝗮𝗻𝗱 𝗶𝗺𝗺𝘂𝗻𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆, underscoring the dynamism of the field. 🔬✨ Equally notable is the 𝘀𝘁𝗿𝗼𝗻𝗴 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻, with delegates representing 𝗰𝗹𝗼𝘀𝗲 𝘁𝗼 𝟮𝟱 𝗻𝗮𝘁𝗶𝗼𝗻𝘀 from across the Asia-Pacific and beyond contributing to rich scientific exchange. This diversity of perspectives continues to position APVIC as a platform where ideas move across borders and disciplines to enable meaningful progress. 🤝🌍 A defining strength of APVIC lies in the close integration between 𝗮𝗰𝗮𝗱𝗲𝗺𝗶𝗮, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗮𝗻𝗱 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆. Throughout the congress, conversations between researchers, clinicians, innovators, and industry partners have helped surface new opportunities for collaboration — from 𝘁𝗿𝗮𝗻𝘀𝗹𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗽𝗶𝗽𝗲𝗹𝗶𝗻𝗲𝘀 𝗮𝗻𝗱 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝘁𝗼 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗱𝗲𝗽𝗹𝗼𝘆𝗺𝗲𝗻𝘁. We are deeply appreciative of the strong engagement from our 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗲𝘅𝗵𝗶𝗯𝗶𝘁𝗼𝗿𝘀 𝗮𝗻𝗱 𝘀𝗽𝗼𝗻𝘀𝗼𝗿𝘀, whose presence has added significant value to the congress. Their contributions help shape APVIC into an interactive ecosystem where scientific discovery is connected directly with innovation, capability building, and impact pathways. A sincere thank you as well to all our 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗰𝗵𝗮𝗶𝗿𝘀 𝗮𝗻𝗱 𝗺𝗼𝗱𝗲𝗿𝗮𝘁𝗼𝗿𝘀— thank you for making Day 2 of APVIC 2026 a highly impactful and energising exchange. Can't wait for Day 3! #APVIC2026 #Vaccines #Immunotherapy #GlobalHealth #TranslationalScience #BiomedicalResearch #Innovation #Collaboration Sara Cherry Evan Newell Lok To Sham Rajiv Khanna Laurent Renia Gavin Smith Mohamed ElSayed, Ph.D. Revvity ProImmune Agilent Technologies ONI QIMR Berghofer CSL Waters Biosciences (Formerly BD Biosciences) Bio-Strategy Part of DKSH Group Immudex Azenta Life Sciences GENEWIZ from Azenta Life Sciences Twist Bioscience Lonza Cell Signaling Technology (CST) 10x Genomics MGI Global Cold Chain Solutions Pte Ltd Cytek Biosciences Singleron Biotechnologies Proteintech Group Promega Corporation MDPI Miltenyi Biotec Temasek Foundation MedChemExpress LLC GenScript